Clinical Trial Update: Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer

View source ↗

Summary

This clinical trial evaluates irreversible electroporation ablation combined with anti-PD-L1 therapy for locally advanced pancreatic cancer; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• PD-1/PD-L1 inhibitor

Snippet

Sponsor: Ruijin Hospital | Conditions: Pancreatic Cancer | Status: NOT_YET_RECRUITING